Literature DB >> 6573871

Height and lymphoblastic leukaemia.

J Broomhall, R May, J S Lilleyman, R D Milner.   

Abstract

Two hundred and thirty six children with untreated lymphoblastic leukaemia were compared for height with the normal population by calculation of their mean standard deviation score. As a group, they proved to be significantly taller (P less than 0.0001), which gives support to the theory that growth hormone or a somatomedin may be involved in the development of the disease.

Entities:  

Mesh：

Year:  1983        PMID： 6573871      PMCID： PMC1627938          DOI： 10.1136/adc.58.4.300

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  6 in total

Review 1.  Mechanism of action of pituitary growth hormone.

Authors:  G P Talwar; M R Pandian; N Kumar; S N Hanjan; R K Saxena; R Krishnaraj; S L Gupta
Journal:  Recent Prog Horm Res       Date:  1975

2.  The natural history of the Silver-Russell syndrome: a longitudinal study of thirty-nine cases.

Authors:  J M Tanner; H Lejarraga; N Cameron
Journal:  Pediatr Res       Date:  1975-08       Impact factor: 3.756

3.  Effect of hypophysectomy on a virus-induced T-cell leukemia.

Authors:  H P Bentley; E R Hughs; R D Peterson
Journal:  Nature       Date:  1974-12-20       Impact factor: 49.962

4.  Effect of treatment of malignant disease on growth in children.

Authors:  N K Griffin; J Wadsworth
Journal:  Arch Dis Child       Date:  1980-08       Impact factor: 3.791

5.  Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. II.

Authors:  J M Tanner; R H Whitehouse; M Takaishi
Journal:  Arch Dis Child       Date:  1966-12       Impact factor: 3.791

6.  Possible effects of growth hormone on development of acute lymphoblastic leukaemia.

Authors:  P C Rogers; D Komp; A Rogol; H Sabio
Journal:  Lancet       Date:  1977-08-27       Impact factor: 79.321
  6 in total
  8 in total

1.  Height and lymphoblastic leukemia.

Authors:  W R McWhirter; K M McWhirter; D Taylor
Journal:  Arch Dis Child       Date:  1983-10       Impact factor: 3.791

2.  Increased prevalence of minor anomalies in childhood malignancy.

Authors:  K Méhes; E Signer; H J Plüss; H J Müller; G Stalder
Journal:  Eur J Pediatr       Date:  1985-09       Impact factor: 3.183

3.  Height and weight pattern up to 20 years after treatment for acute lymphoblastic leukaemia.

Authors:  N H Birkebaek; N Clausen
Journal:  Arch Dis Child       Date:  1998-08       Impact factor: 3.791

4.  Weight gain and height velocity during prolonged first remission from acute lymphoblastic leukaemia.

Authors:  C P Sainsbury; R G Newcombe; I A Hughes
Journal:  Arch Dis Child       Date:  1985-09       Impact factor: 3.791

5.  Impaired pubertal growth in acute lymphoblastic leukaemia.

Authors:  M Uruena; R Stanhope; J M Chessells; A D Leiper
Journal:  Arch Dis Child       Date:  1991-12       Impact factor: 3.791

6.  A prospective study of body mass, height, and smoking on the risk of colorectal cancer in women.

Authors:  C G Chute; W C Willett; G A Colditz; M J Stampfer; J A Baron; B Rosner; F E Speizer
Journal:  Cancer Causes Control       Date:  1991-03       Impact factor: 2.506

7.  Height at diagnosis of malignancies.

Authors:  C H Pui; R K Dodge; S L George; A A Green
Journal:  Arch Dis Child       Date:  1987-05       Impact factor: 3.791

8.  The risk profile of childhood leukaemia in Greece: a nationwide case-control study.

Authors:  E Petridou; D Trichopoulos; V Kalapothaki; A Pourtsidis; M Kogevinas; M Kalmanti; D Koliouskas; H Kosmidis; J P Panagiotou; F Piperopoulou; F Tzortzatou
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.